ResearcherMemorial Sloan Kettering Cancer CenterNo recent work listed

Patrícia M. R. Pereira

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4772-9339; OpenAlex author ID A5003579555. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2020: 2 papers

Papers 2

iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy. Co-author DOI 10.1158/0008-5472.can-19-2991 ↗
ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase Inhibitors. Co-author DOI 10.7150/thno.37098 ↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Freddy E. Escorcia · 2 shared papers, 2020 · strength 0.22
- Paper ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase … DOI 10.7150/thno.37098 ↗
- Paper iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy. DOI 10.1158/0008-5472.can-19-2991 ↗
Jason Stuart Lewis · 2 shared papers, 2020 · strength 0.22
- Paper ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase … DOI 10.7150/thno.37098 ↗
- Paper iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy. DOI 10.1158/0008-5472.can-19-2991 ↗
Jacob L. Houghton · 1 shared paper, 2020 · strength 0.12
- Paper ImmunoPET Predicts Response to Met-targeted Radioligand Therapy in Models of Pancreatic Cancer Resistant to Met Kinase … DOI 10.7150/thno.37098 ↗
Taha Merghoub Merghoub · 1 shared paper, 2020 · strength 0.10
- Paper iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy. DOI 10.1158/0008-5472.can-19-2991 ↗
Christine A. Iacobuzio–Donahue · 1 shared paper, 2020 · strength 0.10
- Paper iNOS Regulates the Therapeutic Response of Pancreatic Cancer Cells to Radiotherapy. DOI 10.1158/0008-5472.can-19-2991 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.